Table 1. Characteristics of the Included Articles.

	Authors	Country	Type of article	Age (years)/sex	Secondary prevention
1	Yaghi et al, 2020 [2]	USA	Case Series	40, 40, 50, 50, 50; sex: NR	Anticoagulant
2	Oxley et al, 2020 [3]	USA	Case series	33/F; 37/M	Apixaban 5 mg twice daily
3	Fara et al, 2020 [4]	USA	Case series	33/F	Aspirin plus clopidogrel then switched to apixaban 5 mg twice daily
4	Ashrafi et al, 2020 [8]	Iran	Case series	33/F; 39/M; 40/M	Aspirin plus clopidogrel
5	Deliwala et al, 2020 [9]	USA	Case report	31/F	Aspirin
6	Reddy et al, 2020 [10]	USA	Case series	47/M; 39/F	Antiplatelet
7	Franceschi et al, 2020 [11]	USA	Case series	33/M; 37/F	Anticoagulant (one of them received argatroban)
Total				16 patients	Anticoagulant: 10; dual antiplatelet: 3; single antiplatelet: 3

M: male; F: female; NR: not reported.